As a result, DCs exposed to CM from EGFR‐mutant tumor cells displayed diminished capacity to prime human CD8+ T cells, as shown their significant reduced proliferation and cytokine secretion (Figure 1k–n). This evidence concerns the gene CD8A and neoplasm.